Related Experiment Video
Updated: Jun 10, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Deciphering Aflatoxin B1 affected critical molecular pathways governing cancer: A bioinformatics study using CTD and
Ankita Kapri1, Dheer Singh1, Suneel Kumar Onteru2
1Molecular Endocrinology, Functional Genomics & Systems Biology Laboratory, Animal Biochemistry Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India.
Aflatoxin B1 (AFB1) exposure impacts key molecular pathways in lung, colorectal, liver, stomach, and breast cancers. This study identifies affected pathways and thirteen potential biomarker genes for AFB1-induced cancers.
Area of Science:
- Toxicology
- Molecular Biology
- Cancer Research
Background:
- Aflatoxin B1 (AFB1) is a potent carcinogenic fungal toxin found in food.
- AFB1 exposure is linked to severe health issues, including hepatotoxicity and various cancers.
- The molecular pathways affected by AFB1 during cancer development are not well understood.
Purpose of the Study:
- To identify molecular pathways significantly altered by AFB1 exposure in five major cancer types.
- To pinpoint key genes that could serve as biomarkers for AFB1-induced cancers.
- To provide insights into AFB1's role in cancer initiation and progression.
Main Methods:
- Selected AFB1-responsive genes from the Comparative Toxicogenomics Database (CTD) for lung, colorectal, liver, stomach, and breast cancers.
- Utilized the PANTHER database for statistical overrepresentation tests to identify affected pathways.
- Performed gene analysis on identified pathways to find potential biomarker genes.
Main Results:
- Identified the gonadotropin-releasing hormone receptor (GnRHR), CCKR signaling, and angiogenesis as significantly affected pathways in multiple cancers.
- AFB1 impacted apoptosis and Wnt signaling pathways in liver and stomach cancers, respectively.
- Wnt, CCKR, and GnRHR pathways were most affected in colorectal cancer.
- Thirteen key genes, including FOS and AKT1, were identified as potential biomarkers.
Conclusions:
- AFB1 significantly affects critical molecular pathways involved in cancer development across multiple cancer types.
- The identified key genes may serve as valuable biomarkers for AFB1-induced cancers and for in vitro toxicological studies.
- Further research into these pathways and genes can elucidate AFB1's carcinogenic mechanisms.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...